Flora Growth Corp. Participates in U.S. Hemp Roundtable Meetings to Advocate for Effective Legislation on Capitol Hill
Flora Growth Corp. (NASDAQ: FLGC) participated in the U.S. Hemp Roundtable's advocacy meetings in Washington, D.C., aimed at advancing legislation to support the hemp industry. Clifford Starke, Flora's Chairman and CEO, represented the company in discussions with lawmakers and congressional staffers. The meetings focused on advocating for clearer federal regulations, improved market access, and stronger protections for hemp-derived products.
Key topics included the need for clearer federal oversight of hemp-derived cannabinoids and ensuring the future of the U.S. hemp industry amid evolving policies. Mr. Starke expressed optimism about the outcomes, emphasizing Flora's commitment to being at the forefront of shaping the industry's regulatory landscape. The U.S. Hemp Roundtable, of which Mr. Starke is the Chairman, aims to promote sensible, science-based hemp regulations and create a clear path forward for the industry's growth.
Flora Growth Corp. (NASDAQ: FLGC) ha partecipato alle riunioni di advocacy del U.S. Hemp Roundtable a Washington D.C., mirate a promuovere legislazioni a sostegno dell'industria della canapa. Clifford Starke, Presidente e CEO di Flora, ha rappresentato l'azienda nei colloqui con i legislatori e il personale congressuale. Le riunioni si sono concentrate sulla promozione di regolamenti federali più chiari, un accesso al mercato migliorato e una protezione più forte per i prodotti derivati dalla canapa.
I temi principali comprendevano la necessità di una supervisione federale più chiara dei cannabinoidi derivati dalla canapa e la garanzia del futuro dell'industria della canapa negli Stati Uniti in un contesto di politiche in evoluzione. Il signor Starke ha espresso ottimismo riguardo ai risultati, sottolineando l'impegno di Flora di essere all'avanguardia nella definizione del panorama normativo dell'industria. Il U.S. Hemp Roundtable, di cui il signor Starke è Presidente, mira a promuovere regolamenti sulla canapa sensati e basati sulla scienza, creando un percorso chiaro per la crescita dell'industria.
Flora Growth Corp. (NASDAQ: FLGC) participó en las reuniones de defensa del U.S. Hemp Roundtable en Washington, D.C., con el objetivo de promover legislaciones que apoyen la industria del cáñamo. Clifford Starke, Presidente y CEO de Flora, representó a la compañía en discusiones con legisladores y personal del Congreso. Las reuniones se centraron en abogar por regulaciones federales más claras, un mejor acceso al mercado y una protección más sólida para los productos derivados del cáñamo.
Los temas clave incluyeron la necesidad de una supervisión federal más clara sobre los cannabinoides derivados del cáñamo y de asegurar el futuro de la industria del cáñamo en EE. UU. ante políticas en evolución. El Sr. Starke expresó optimismo sobre los resultados, enfatizando el compromiso de Flora de estar a la vanguardia en la configuración del panorama regulatorio de la industria. El U.S. Hemp Roundtable, del cual el Sr. Starke es Presidente, tiene como objetivo promover regulaciones sensatas basadas en la ciencia y crear un camino claro hacia el crecimiento de la industria.
Flora Growth Corp. (NASDAQ: FLGC)는 미국 대마 원탁회의의 옹호 회의에 참가하여 대마 산업을 지원하는 법안을 발전시키기 위해 워싱턴 D.C.에서 활동했습니다. 클리포드 스타크는 Flora의 회장 겸 CEO로서 법률가 및 의회 직원과의 논의에서 회사를 대표했습니다. 회의는 더 명확한 연방 규정, 향상된 시장 접근성 및 대마 유래 제품에 대한 보다 강력한 보호를 옹호하는 데 초점을 맞추었습니다.
주요 주제는 대마에서 유래된 칸나비노이드에 대한 보다 명확한 연방 감독의 필요성과 변화하는 정책 속에서 미국 대마 산업의 미래를 보장하는 것이었습니다. 스타크 씨는 결과에 대한 낙관론을 표현하며 Flora의 산업 규제 환경을 형성하는 최전선에 서겠다는 약속을 강조했습니다. 스타크 씨가 의장으로 활동하는 미국 대마 원탁회의는 합리적이고 과학에 기반한 대마 규정을 촉진하고 산업의 성장을 위한 명확한 경로를 만드는 것을 목표로 하고 있습니다.
Flora Growth Corp. (NASDAQ: FLGC) a participé aux réunions de plaidoyer du U.S. Hemp Roundtable à Washington D.C., visant à avancer des législations pour soutenir l'industrie du chanvre. Clifford Starke, Président et CEO de Flora, a représenté l'entreprise lors de discussions avec des législateurs et le personnel du Congrès. Les réunions se sont concentrées sur la promotion de règlementations fédérales plus claires, un meilleur accès au marché et une protection renforcée des produits dérivés du chanvre.
Parmi les sujets clés figuraient la nécessité d'une surveillance fédérale plus claire des cannabinoïdes dérivés du chanvre et la garantie de l'avenir de l'industrie du chanvre américain face à des politiques en évolution. M. Starke a exprimé un optimisme quant aux résultats, soulignant l'engagement de Flora à être à l'avant-garde de la définition du paysage réglementaire de l'industrie. Le U.S. Hemp Roundtable, dont M. Starke est le Président, vise à promouvoir des réglementations sur le chanvre sensées et basées sur la science, tout en créant un chemin clair vers la croissance de l'industrie.
Flora Growth Corp. (NASDAQ: FLGC) nahm an den Lobby-Treffen des U.S. Hemp Roundtable in Washington D.C. teil, die darauf abzielten, Gesetzesentwürfe zur Unterstützung der Hanfindustrie voranzutreiben. Clifford Starke, der Vorsitzende und CEO von Flora, vertreten das Unternehmen in Gesprächen mit Gesetzgebern und Mitarbeitern des Kongresses. Die Treffen konzentrierten sich auf die Förderung von klareren bundesstaatlichen Vorschriften, verbessertem Marktzugang und stärkeren Schutzmaßnahmen für Hanfprodukte.
Wichtige Themen waren die Notwendigkeit einer klareren bundesstaatlichen Aufsicht über hanfbasierte Cannabinoide und die Sicherstellung der Zukunft der amerikanischen Hanfindustrie angesichts sich ändernder Politiken. Herr Starke äußerte Optimismus bezüglich der Ergebnisse und betonte Floras Engagement, an der Spitze der Regulierung der Industrie zu stehen. Der U.S. Hemp Roundtable, dessen Vorsitzender Herr Starke ist, hat sich zum Ziel gesetzt, sinnvolle, wissenschaftlich fundierte Hanfvorschriften zu fördern und einen klaren Weg für das Wachstum der Branche zu schaffen.
- Flora Growth's CEO participated in high-level advocacy meetings with lawmakers
- The company is actively involved in shaping hemp industry regulations
- Flora's CEO holds a leadership position as Chairman of the U.S. Hemp Roundtable
- None.
Insights
Flora Growth's participation in the U.S. Hemp Roundtable meetings signals a proactive approach to shaping hemp industry regulations. The focus on clearer federal oversight and improved market access could potentially benefit companies like Flora in the long run. However, the immediate impact on the company's financials or operations is likely minimal.
Key points to consider:
- Advocacy for clearer regulations may reduce legal uncertainties, potentially lowering compliance costs in the future.
- Improved market access could expand business opportunities, but this is a long-term prospect.
- Flora's CEO's role as Chairman of the U.S. Hemp Roundtable positions the company as an industry leader, which may enhance its reputation.
While these efforts are important for the industry's future, they don't represent immediate, tangible changes to Flora's business model or financial outlook. Investors should view this as part of the company's long-term strategy rather than a catalyst for short-term stock movement.
Fort Lauderdale, Florida--(Newsfile Corp. - September 25, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce its participation in the U.S. Hemp Roundtable's recent advocacy meetings in Washington, D.C. The meetings, aimed at advancing legislation to support the hemp industry, included key discussions with lawmakers as well as health and agriculture staffers from several congressional offices.
Representing Flora at the meetings was Clifford Starke, Chairman and Chief Executive Officer, who alongside other industry leaders, advocated for clearer federal regulations, improved market access, and stronger protections for hemp-derived products. Flora's participation underscores the Company's commitment to being at the forefront of legislation and regulatory processes shaping the U.S. hemp industry.
The meetings focused on a range of important topics, including the need for clearer federal oversight of hemp-derived cannabinoids, and ensuring the future of the U.S. hemp industry amid evolving agricultural and health-related policies.
Mr. Starke expressed his optimism about the outcomes of the meetings: "as one of the leading voices in the industry, Flora is proud to have been part of the U.S. Hemp Roundtable's important advocacy work. We were provided with a valuable platform to address the critical issues facing the industry today. We push for sensible and effective regulations that protect consumers, ensure product safety, and enable long-term growth for the entire sector."
"Our industry is working tirelessly to bring sensible, science-based hemp regulations to the forefront of Washington's agenda," said Jonathan Miller, General Counsel for the U.S. Hemp Roundtable. "Through collaborative advocacy and education, we are ensuring that policymakers understand the immense potential of hemp and CBD products, while promoting a regulatory framework that prioritizes safety, consumer confidence, and innovation. Our goal is to create a clear and fair path forward that supports the growth of the hemp industry and benefits farmers, businesses, and consumers alike."
Mr. Starke is the Chairman of the U.S. Hemp Roundtable. It is a coalition of leading companies and organizations with the objective of ensuring the long-term viability of the hemp industry in the United States.
About Flora Growth Corp.
Flora Growth Corp.'s mission is to become the leading NASDAQ small-cap international cannabis company. FLGC is a cannabis-focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world. For more information on Flora, visit www.floragrowth.com.
https://www.phatebo.de/home-en
https://www.australianvaporizers.com.au/
Investor Relations:
Investor Relations ir@floragrowth.com
Clifford Starke Clifford.Starke@floragrowth.com
Media:
Cautionary Statement Concerning Forward-Looking Statements
This press release contains "forward-looking statements," as defined by U.S. federal securities laws. Forward-looking statements reflect Flora's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words "believe," "expect," "anticipate," "will," "could," "would," "should," "may," "plan," "estimate," "intend," "predict," "potential," "continue," and the negatives of these words and other similar expressions generally identify forward-looking statements. Such forward-looking statements are subject to various and risks and uncertainties, including those described under section entitled "Risk Factors" in Flora's Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the "SEC") on March 28, 2024, as such factors may be updated from time to time in Flora's periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov/edgar. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora's filings with the SEC. While forward-looking statements reflect Flora's good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to Flora (or to third parties making the forward-looking statements).
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/224320
FAQ
What was the purpose of Flora Growth Corp's (FLGC) participation in the U.S. Hemp Roundtable meetings?
Who represented Flora Growth Corp. (FLGC) at the U.S. Hemp Roundtable meetings in Washington, D.C.?
What key topics were discussed during the U.S. Hemp Roundtable meetings involving Flora Growth Corp. (FLGC)?
What position does Flora Growth Corp's (FLGC) CEO hold in the U.S. Hemp Roundtable?
